Investigational Rotavirus Vaccine In Late-Stage Clinical Trials

Reuters: Sanofi’s Rotavirus vaccine enters late-stage trials “French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea had entered late-stage clinical trials in India. The vaccine is aimed at rotavirus infections which cause gastroenteritis…” (Callus, 10/14). …read more

We suggest you read  South Africa is using thermal technology to detect travellers with the Wuhan coronavirus
https://www.ampronix.com/?utm_source=Africa_Health_Banner&utm_medium=referral&utm_campaign=website-banner
Share